Application of Comparative Genomic Hybridization, Spectral Karyotyping, and Microarray Analysis in the Identification of Subtype-Specific Patterns of Genomic Changes in Rhabdomyosarcoma

Neoplasia

Volumn 1, Issue 3, 1999, Pages 262-275

  Pandita, Ajay ^a   Zielenska, Maria ^b   Thorner, Paul ^b   Bayani, Jane ^a   Godbout, Roseline ^c   Greenberg, Mark ^b   Squire, Jeremy A ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CROSS CANCER INSTITUTE   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

CGH; Microarray; Rhabdomyosarcoma; SKY

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CHROMOSOME ABERRATION; CHROMOSOME BANDING PATTERN; CHROMOSOME MAP; GENE AMPLIFICATION; GENETICS; HUMAN; KARYOTYPING; NUCLEIC ACID HYBRIDIZATION; RHABDOMYOSARCOMA;

CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME MAPPING; DNA, COMPLEMENTARY; GENE AMPLIFICATION; HUMANS; KARYOTYPING; NUCLEIC ACID HYBRIDIZATION; RHABDOMYOSARCOMA;

EID: 0033170602     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900036     Document Type: Article

References (60)

1. Newton WA, Jr, Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB, Tsokos MG, Shimada H, Harms D, Schmidt D (1995). Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification - an Intergroup Rhabdomyosarcoma Study. Cancer 76, 1073-1085.
2. Diller L (1992). Rhabdomyosarcoma and other soft tissue sarcomas of childhood. Curr Opin Oncol 4, 689-695.
3. Scrable H, Witte D, Shimada H, Seemayer T, Wang-Wuu S, Soukup S, Koufos A, Houghton P, Lampkin B, and Cavenee W (1989). Molecular Differential Pathology of Rhabdomyosarcoma. Genes Chromosomes Cancer 1, 23-25.
4. Galili N, Davis R, Fredericks W, Mukhopadhyay S, Rauscher III F, Emanuel B, Rovera G, and Barr F (1993). Fusion of a fork head domain gene to PAX3 in the solid tumor alveolar rhabdomyosarcoma. Nat Genet 5, 230-235.
5. Barr F, Nauta L, Davis R, Schäfer B, Nycum L, and Biegel J (1996). In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum Mol Genet 5, 15-21.
6. Davis R, D'Cruz C, Lovell M, Biegel J, and Barr F (1994). Fusion of PAX7 to FKHR by the variant t(1,13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54, 2869-2872.
7. Scrable H, Cavenee W, Ghavimi F, Lovell M, Morgan K, and Sapienza C (1989). A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting. Proc Natl Acad Sci USA 86, 7480-7484.
8. Sandberg A, and Bridge E (1994). The cytogenetics of bone and soft tissue tumors. RG Landes, Austin, TX.
9. Forozan F, Karhu R, Kononen J, Kallioniemi A, and Kallioniemi OP (1997). Genome screening by comparative genomic hybridization. Trends Genet 13, 405-409.
10. Knuutila S, Bjorkqvist A, Aautio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy M, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius V, Vidgren V, and Zhu Y (1998). DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization. Am J Pathol 152, 1107-1123.
11. Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, and Ried T (1996). Multicolor spectral karyotyping of human chromosomes [see comments]. Science 273, 494-497.
12. Speicher MR, Gwyn Ballard S, and Ward DC (1996). Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12, 368-375.
13. Weber-Hall S, Anderson J, McManus A, Abe S, Nojima T, Pinkerton R, Pritchard-Jones K, and Shipley J (1996). Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 56, 3220-3224.
14. Bayani J, Thorner P, Zielenska M, Pandita A, Beatty B, and Squire JA (1995). Application of a simplified comparative genomic hybridization technique to screen for gene amplification in pediatric solid tumors. Pediatr Pathol Lab Med 15, 831-844.
15. Steilen-Gimbel H, Remberger K, Graf N, Steudel WI, Zang KD, and Henn W (1996). A novel site of DNA amplification on chromosome 1p32-33 in a rhabdomyosarcoma revealed by comparative genomic hybridization. Hum Genet 97, 87-90.
16. Dias P, Kumar P, Marsden HB, Gattamaneni HR, Heighway J, and Kumar S (1990). N-myc gene is amplified in alveolar rhabdomyosarcomas (RMS) but not in embryonal RMS. Int J Cancer 45, 593-596.
17. Driman D, Thorner PS, Greenberg ML, MacNeil-Chilton S, and Squire J (1994). MYCN gene amplifications in rhabdomyosarcoma. Cancer 73, 2231-2237.
18. Godbout R, and Squire J (1993). Amplification of a DEAD box protein gene in retinoblastoma cell lines. Proc Natl Acad Sci USA 90, 7578-7582.
19. Amler L, Schurmann J, and Schwab M (1996). The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastoma. Genes Chromosomes Cancer 15, 134-137.
20. George RE, Kenyon RM, McGuckin AG, Malcolm AJ, Pearson AD, and Lunec J (1996). Investigation of co-amplification of the candidate genes ornithine decarboxylase; ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. Oncogene 12, 1583-1587.
21. Manohar C, Salwen H, Brodeur G, and Cohn S (1995). Co-amplification and concomitant high levels of expression of a DEAD box gene with N-MYC in human neuroblastoma. Genes Chromosomes Cancer 196-203.
22. Noguchi T, Akiyama K, Yokoyama M, Kanda N, Matsunaga T, and Nishi Y (1996). Amplification of a DEAD box gene (DDX1) with the MYCN gene in Neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus. Genes Chromosomes Cancer 15, 129-133.
23. Squire J, Thorner P, Weitzman S, Maggi J, Dirks P, Doyle J, Hale M, and Godbout R (1995). Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene 10, 1417-1422.
24. Houghton JA, Houghton PJ, Brodeur GM, and Green AA (1981). Development of resistance to vincristine in a childhood rhabdomyosarcoma growing in immune-deprived mice. Int J Cancer 28, 409-415.
25. Roberts W, Douglass E, Peiper S, Houghton P, and Look A (1989). Amplification of the gli Gene in Childhood Sarcomas. Cancer Res 49, 5407-5413.
26. Dracopoli NC (1999). Current Protocols in Human Genetics. John Wiley and Sons, New York.
27. Kallioniemi O, Kallioniemi A, Sudar D, Rutovitz D, Gray J, Waldman F, and Pinkel D (1992). Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258, 818-821.
28. Tumilowicz JJ, Nichols WW, Cholon JJ, and Greene AE (1970). Definition of a continuous human cell line derived from neuroblastoma. Cancer Res 30, 2110-2118.
29. Veldman T, Vignon C, Schrock E, Rowley JD, and Ried T (1997). Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 15, 406-410.
30. DeRisi J, Penland L, Brown P, Bittner M, Meltzer P, Ray M, Chen Y, Su Y, and Trent J (1996). Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 14, 457-460.
31. DeRisi J, Iyer V, and Brown P (1997). Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680-686.
32. Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, and Sturhl K (1998). Current Protocols in Molecular Biology. John Wiley and Sons, New York.
33. Dodd S, Malone M, and McCulloch W (1989). Rhabdomyosarcoma in children: A histological and immunohistochemical study of 59 cases. J Pathol 158, 13-18.
34. Parham DM, Webber B, Holt H, Williams WK, and Maurer H (1991). Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Results of an Intergroup Rhabdomyosarcoma study project. Cancer 67, 3072-3080.
35. Heim S, and Mitelman F (1994). Cancer Cytogenetics. Alan R. Liss, New York.
36. Trent J, Casper J, Meltzer P, Thompson F, and Fogh J (1985). Nonrandom chromosome alterations in rhabdomyosarcoma. Cancer Genet Cytogenet 16, 189-197.
37. Wang-Wuu S, Soukup S, Ballard E, Gotwals B, and Lampkin B (1988). Chromosomal analysis of sixteen human rhabdomyosarcoma. Cancer Res 48, 983-987.
38. Weber-Hall S, McManus A, Anderson J, Nojima T, Abe S, Pritchard-Jones K, and Shipley J (1996). Novel formation and amplification of the PAX7-FKHR fusion gene in a case of alveolar rhabdomyosarcoma. Genes Chromosomes Cancer 17, 7-13.
39. Hachitanda Y, Toyoshima S, Akazawa K, and Tsuneyoshi M (1998). N-myc gene amplification in rhabdomyosarcoma detected by fluorescence in situ hybridization: Its correlation with histologic features. Mod Pathol 11, 1222-1227.
40. Schmid SR, and Linder P (1992). DEAD protein family of putative RNA helicases. Mol Microbiol 6, 283-291.
41. Iost I, and Dreyfus M (1994). mRNA can be stabilized by DEAD-box proteins. Nature 372, 193-196.
42. Buelt MK, Glidden BJ, and Storm DR (1994). Regulation of p68 RNA helicase by calmodulin and protein kinase C. J Biol Chem 269, 29367-29370.
43. Py B, Higgins CF, Krisch HM, and Carpousis AJ (1996). A DEAD-box RNA helicase in the Escherichia coli RNA degradosome. Nature 381, 169-172.
44. Rozen F, Edery I, Meerovitch K, Dever TE, Merrick WC, and Sonenberg N (1990). Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol Cell Biol 10, 1134-1144.
45. Godbout R, Packer M, and Bie W (1998). Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines. J Biol Chem 273, 21161-21168.
46. George R, Thomas H, McGuckin A, Angus B, Newell D, Pearson A, and Lunec J (1998). The DDX1 gene which is frequently co-amplified with MYCN in primary neuroblastoma is itself tumorigenic. Proc Am Assoc Cancer Res 39, Abstract # 3205.
47. Ladanyi M, Jhanwar S, Healey J, and Huvos A (1994). MDM2 amplification in Ewing's sarcoma. Lab Invest 70, 147A.
48. Oliner J, Kinzler K, Meltzer P, George D, and Volgelstein B (1992). Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358, 80-83.
49. Goker E, Waltham M, Kheradpour A, Trippett T, Mazumdar M, Elisseyeff Y, Schnieders B, Steinherz P, Tan C, Berman E (1995). Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood 86, 677-684.
50. Hartwell L (1992). Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71, 543-546.
51. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ, and Look AT (1993). Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53, 5535-5541.
52. Meddeb M, Valent A, Danglot G, Nguyen VC, Duverger A, Fouquet F, Terrier-Lacombe MJ, Oberlin O, and Bemheim A (1996). MDM2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14). Cytogenet Cell Genet 73, 325-330.
53. Thorner P, Squire J, Chilton-MacNeil S, Marrano P, Bayani J, Malkin D, Greenberg M, Lorenzana A, and Zielenska M (1996). Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types. Am J Pathol 148, 1125-1138.
54. Waber PG, Chen J, and Nisen PD (1993). Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas. Cancer Res 53, 6028-6030.
55. Wang-Peng J, Knutsen T, Theil K, Horowitz M, and Triche T (1992). Cytogenetic Studies in Subgroups of Rhabdomyosarcoma. Genes Chromosomes Cancer 5, 299-310.
56. Biegel JA, Nycum LM, Valentine V, Barr FG, and Shapiro DN (1995). Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization. Genes Chromosomes Cancer 12, 186-192.
57. Ferracini R, Olivero M, Di Renzo MF, Martano M, De Giovanni C, Nanni P, Basso G, Scotlandi K, Lollini PL, and Comoglio PM (1996). Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 12, 1697-1705.
58. Ginsberg JP, Davis RJ, Bennicelli JL, Nauta LE, and Barr FG (1998). Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma. Cancer Res 58, 3542-3546.
59. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, and Meltzer PS (1998). Gene expression profiling of alveolar rhabdomyosarcoma with DNA micro-arrays. Cancer Res 58, 5009-5013.
60. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, and Vogelstein B (1998). Mutations of mitotic checkpoint genes in human cancers [see comments]. Nature 392, 300-303.